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Background
Maternal psychopathology during pregnancy is associated with
negative outcomes in offspring. Increased placental transfer of
maternal cortisol may contribute to mediate this association.
Hair cortisol concentrations (HCCs) appear to be a good bio-
marker of long-term prenatal stress exposure. Little is known
about the associations between severe maternal psychopath-
ology and perinatal infant HCCs.
Aims
We assessed HCCs in the perinatal period in mother–infant
dyads with and without severe psychiatric disorders.
Method
We examined group differences in HCCs of mother–infant dyads
(n = 18) subjected to severe maternal psychiatric disorders ver-
sus healthy control dyads (n = 27). We assessed the correlation
of HCCs between mother and infant within both groups, and the
association between current maternal symptoms and HCCs in
patient dyads.
Results
Median (interquartile range) and distribution of HCC differed in
patients compared with control mothers (U = 468.5, P = 0.03).
HCCs in infants of patients did not differ from control infants
(U = 250.0, P = 0.67). Subsequently, we found that HCCs within
healthy control dyads were correlated (n = 27, r 0.55 (0.14),
P = 0.003), but were not within patient dyads (n = 18, r 0.082
(0.13), P = 0.746). HCCs in infants of patients showed a positive
correlation with maternal symptoms (n = 16, r = 0.63 (0.06),
P = 0.008).
Conclusions
These preliminary findings suggest that infant HCC reflect peri-
natal stress exposure. In infants, these early differences could
influence lifetime hypothalamic–pituitary–adrenal axis function-
ing, which might be associated with increased susceptibility to
later disease.
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Children of mothers with psychiatric disorders during pregnancy
are at high risk for developing physical and psychiatric disorders
later in life.1,2 Maternal psychopathology and stress during preg-
nancy are among the most common intrauterine exposures asso-
ciated with negative outcomes in offspring, with prevalence rates
of 10–15% for depression and anxiety disorders.3–5 Psychiatric dis-
orders are associated with alterations in basal cortisol levels and dis-
turbed variability of the stress response owing to dysregulation of
the hypothalamic–pituitary–adrenal (HPA) axis.6,7 Accumulating
research suggests placental transfer of maternal cortisol might
play a mediating role in the effects of maternal psychopathology
on the neurocognitive and physical development of the foetus,8
and increased prenatal maternal cortisol levels have been repeatedly
linked to adverse child outcomes in the short and long term, such as
lower birth weight, small for gestational age, intellectual disability
and behavioural problems.9–11 As most previous research has
focused on less-affected individuals, the specific aim of this study
is to explore the effect of severe and long-lasting psychiatric disor-
ders during pregnancy on early hair cortisol concentrations (HCCs)
in mother–infant dyads.
Hair cortisol is a reliable biomarker reflecting chronic systemic
cortisol levels,12,13 as well as stress exposure.14,15 Maternal HCC at
6 weeks’ postpartum probably reliably reflects cortisol exposure in
the preceding 3 months, which allows us to quantify cortisol expos-
ure from the last 6 weeks of pregnancy to the first 6 weeks’ post-
partum.16,17 In very young infants, less is known about the exact
timeframe of exposure, but supposedly HCC reflects cortisol expos-
ure in the intrauterine milieu during late pregnancy and early post-
partum cortisol exposure.18
HPA axis and psychiatric disorders
The relationship between psychopathology and HPA axis devia-
tions in general has not been fully elucidated. Specific psychiatric
diagnoses, such as major depressive disorder, bipolar disorder and
schizophrenia, have been linked to higher basal cortisol levels,
whereas anxiety disorders have been associated with a combined
profile of higher levels of cortisol during acute stress and lower base-
line cortisol levels.19,20 The latter finding of lower baseline cortisol
levels has also been found in studies on borderline personality dis-
order.21 Post-traumatic stress disorder has been generally linked to
lower cortisol levels; however, cortisol appears to be elevated when
the traumatic event has happened more recently, or when traumatic
BJPsych Open (2021)
7, e28, 1–9. doi: 10.1192/bjo.2020.159
1
Downloaded from https://www.cambridge.org/core. 13 Jan 2021 at 10:22:15, subject to the Cambridge Core terms of use.
circumstances are still present.22,23 It has been proposed there is a
non-linear, two-stage timeline with regard to cortisol dysfunction
in relation to trauma: the severity of traumatisation and more tem-
porally distant traumatisation were related to lower HCC, whereas
higher HCC was found in more recently traumatised individuals.24
Similarly, in depression, it has been found that recurring episodes
are associated with lower HCC. This evidence leads to the hypoth-
esis that chronic overactivation of the stress response leads to
blunted HPA axis activity over time, indicating that the severity
and duration of stress activity might be a more important determin-
ant of basal cortisol levels in patients with severe and long-lasting
psychiatric disorders than the nature of the psychiatric
diagnosis.25,26
Maternal HPA axis functioning and its influence on the
foetus
Altered HPA axis activity in mothers who suffer from severe psychi-
atric disorders can influence the foetus through intrauterine pro-
gramming of the HPA axis.19,27 There is some evidence that these
early alterations in HPA axis functioning contribute to vulnerability
to psychiatric disease in offspring later in life,28 by early fine-tuning
of the HPA axis set point.
Under normal conditions, in the absence of psychopathology or
severe stress, maternal and infant cortisol and cortisol responses
appear to be positively correlated shortly after birth.29,30 This
finding is mainly based on research with saliva cortisol, but has
been confirmed in animal studies on hair cortisol31 and in studies
on healthy mother–infant dyads.17
Studies evaluating the effects of stress and psychopathology on
maternal and foetal HCC during pregnancy and beyond are rapidly
emerging, but results are inconclusive.32–38 This might be partly
explained by differences in study sample (i.e. healthy versus
depressed mothers) and different definitions of ‘stress’ (i.e. per-
ceived stress versus psychiatric symptom scales). Inconsistent
results have emerged on the association between maternal prenatal
cortisol levels and self-reports of prenatal psychological distress, ele-
vated symptoms of prenatal depression, anxiety and antidepressant
use. Evidence in different studies does show that excess maternal
cortisol during pregnancy is associated with decreased infant corti-
sol levels, as measured in infant hair, shortly after birth33,39 and at 12
months’ postpartum.34 In 2-year-old children, Bryson et al40 found
a significant association between maternal and infant HCC that was
not mediated by measures of early childhood adversity.
Furthermore, two studies found that elevated maternal HCC
during pregnancy mediated disrupted mother–child interaction in
early infancy.26,41 These results suggest that maternal stress (i.e. psy-
chiatric symptoms) is inconsistently related to maternal and/or
infant HCC, but independently, maternal HCC seems to influence
infant cortisol and mother–child interaction both in the early post-
partum period and beyond.
The underlying mechanism of transmission of maternal psy-
chopathology during pregnancy through cortisol remains unclear,
as cortisol attunement between mother and foetus is composed of
complex intrauterine interactions between the maternal, placental
and foetal endocrine systems. The placental barrier is not com-
pletely impenetrable for transfer of cortisol, as a small proportion
(10–20%) of maternal cortisol does reach the foetus.42 However,
in stressful situations, more cortisol can cross the placental
barrier.43,44 Thus, it has been proposed that in stressed mothers,
the excess of maternal cortisol levels leads to downregulation of cor-
tisol production in the foetal adrenal,33 altering the set point of HPA
axis functioning in the foetus. Because psychiatric disorders are
associated with altered HPA axis activity, and this is associated
with suboptimal HPA axis functioning of the infant, more insight
into this process is needed in clinical and healthy dyads, to under-
stand contributing factors and ultimately prevent adverse outcomes
for offspring.
Hypotheses
In the current study, we assessed the association between severe and
long-lasting psychiatric disorders andHCCs of mothers and infants.
We compared HCCs of patient dyads to healthy control dyads at 6
weeks’ postpartum, to further elucidate mechanisms associated with
the transgenerational transmission of psychopathology. In accord-
ance with previous studies demonstrating that psychiatric disorders
are associated with differential HPA axis disturbances, we expected
larger variance in cortisol concentrations in our patient group than
in controls. Subsequently, we assessed the effect of the severity of
current maternal symptoms on infant HCC.
Also, we expected infant HCC to be associated with maternal
perinatal HCC in healthy dyads. Previous research shows that in
healthy mother–infant dyads, maternal and infant HCC appear to
be positively correlated. Therefore, we expected to find an attuned
association of HCC in control dyads. Because maternal psychopath-
ology is associated with both increased and decreased maternal cor-
tisol levels, influenced by the nature, chronicity and genetic
heritability of the psychiatric disorder, we expected to find a diver-
gence of this pattern in mothers and infants who were subject to
maternal severe psychiatric disorders.
Method
Study procedure and design
The current study was embedded in an observational study on par-
enting capacity of mothers with severe psychiatric disorders and
their infant’s cognitive and socio-emotional development (the
Infant Caregiving Assessment Scales (INCAS) study). All mothers
fulfilled criteria for a current severe psychiatric disorder. A
common definition of severe psychiatric disorders, or ‘severe
mental illness’, consists of having any psychiatric diagnosis with a
treatment duration of 2 years or more, together with dysfunction,
as indicated by lower scores on the Global Assessment of
Functioning scale.45 Common disorders that are referred to are
schizophrenia, mood disorders (chronic depression, bipolar dis-
order), chronic anxiety and personality disorders.46
During pregnancy, mothers with severe psychiatric disorders
were recruited from specialised psychiatry-obstetrics-paediatric sec-
ondary and tertiary out-patient clinics and other specialised mental
healthcare institutions where pregnant women who suffer from psy-
chiatric disorders are treated. Healthy control mothers, without
current or a history of psychiatric symptoms, were recruited
during pregnancy at midwifery practices in the central western
part of the Netherlands, consisting primarily of the four largest
Dutch cities and their surrounding areas.
The INCAS study was approved by the Erasmus University
Medical Center Medical Research Ethics Committee (approval
number NL42662.078.12); written informed consent was obtained
from all mothers for their own and their infant’s participation,
and from fathers with legal guardianship.
Exclusion criteria
In the current study, exclusion criteria for both groups were insuf-
ficient amount of hair necessary for cortisol analysis; use of locally
administered and systemic corticosteroids during or after preg-
nancy; use of illicit drugs or alcohol in the last trimester of preg-
nancy; and perinatal complications, including prematurity.
Additionally, control dyads were excluded from analysis when
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maternal global score on the Brief Symptom Inventory (BSI) was in
the clinical range or when mothers used psychotropic medication.47
Inclusion of clinical sample
From June 2013 to January 2016, patients and control mothers were
included in the INCAS study during their third trimester of preg-
nancy (N = 129). A total of 64% of participating mothers (n = 83)
agreed on hair donation at 46 ± 8.5 days’ postpartum (range 34–84
days) for themselves, and 45% for their infant (n = 58). After exclu-
sion based on the aforementioned exclusion criteria, HCCs were
available for a total of 73 mothers (patient n = 33, control n = 40)
and 47 infants (infant of patient n = 20, control infant n = 27)
(see flowchart in Appendix).
Non-response analyses, comparing mothers and infants who did
and did not donate hair for cortisol measurement, showed no
differences with regards to maternal age, ethnicity, educational level,
psychiatric symptoms, and infant birth weight or gestational age.
Measures
HCCs
Mother and child HCCs were determined from hair strands col-
lected 6 weeks’ postpartum (46 days ± 8.5, range 34–84 days). All
samples were collected according to researcher protocol. In adults,
scalp hair has a predictable growth rate of approximately 1 cm
per month, making it possible to have an estimate of long-term
exposure to cortisol.48,49 When collected at 6 weeks’ postpartum,
HCC in the proximal 3 cm of maternal hair reflects the maternal
HPA axis activity over the first 6 weeks after childbirth and the
last 6 weeks of pregnancy.16
A small strand of hair was cut from the posterior vertex of the
scalp, as close as possible to the scalp. Hair strands were taped to
a piece of paper with the scalp end marked, and stored in an enve-
lope at room temperature until further analysis. The proximal 3 cm
of maternal hair samples were weighed and minced. For infants, the
full length of the hair was analysed with a minimum of 1.25 mg, for
reliable measurement. For extraction of cortisol, LC-grademethanol
was used at 25°C, for 18 h, in the presence of labelled glucocorti-
coids as internal standard. The extraction was centrifuged and
cleaned. Cortisol concentrations were quantified by liquid chroma-
tography with tandem mass spectrometry (Waters XEVO-TQ-S
system; Waters Corporation, Milford, MA, USA). Measurements
were reported in picograms per milligram of hair, and log-trans-
formed (10log) to approach normality.50
Psychiatric diagnosis and current symptoms
Presence and history of psychiatric diagnoses were examined with
the Structured Clinical Interview for DSM-IV Axis I Disorders
(SCID-I) and Structured Clinical Interview for DSM-IV Axis II
Disorders (SCID-II), by a trained interviewer.51,52 SCID-I and
SCID-II are considered to be the gold standard of semi-structured
assessment instruments for clinical psychiatric disorders, with
adequate to excellent validity and interrater reliability.53
Level of current symptoms in both the patient and control
group were measured with the BSI, at 6 weeks’ postpartum.54
Severity of stress was indicated by the Global Severity Index
(GSI).55 The BSI comprises 53 items on nine symptom dimensions
(somatisation, obsession–compulsion, interpersonal sensitivity,
depression, anxiety, hostility, phobic anxiety, paranoid ideation
and psychoticism). The GSI presents the mean BSI score.
Normative data are available for clinical and non-clinical samples.
The BSI has a high internal consistency, moderate test–retest reli-
ability and strong convergent validity with measures of emotional
functioning.47 In our sample, Cronbach’s alpha was 0.93 in patients
and 0.82 in controls.
Covariates and potential confounders
Demographic data; information on smoking, alcohol and illicit drug
use; and exposure to psychotropic medication during pregnancy
were collected during the third trimester of pregnancy (patients)
and at 6 weeks’ postpartum (controls), using self-reports.
Confounders were selected a priori, based on previous research.56,57
The following confounders were controlled for the following: child
gender, gestational age and birth weight; and maternal age, ethni-
city, socioeconomic status, parity (primiparity versus multiparity),
tobacco use and use of psychotropic medication.
Data analyses
Demographic and clinical characteristics of the control and patient
sample are reported, and differences between the samples were
tested with χ2-tests (for categorical variables) and t-tests or Mann–
Whitney U-tests (for continuous variables). Differences in HCCs
between patient and control mothers, for diagnostic subgroups in
the patient group, and between infants, were tested using Mann–
Whitney U-tests. For this purpose, HCCs were log-transformed.
We estimated the association betweenmaternal and infant HCC
in both the patient and control sample by regression analysis.
Preliminary analyses did not show significant correlations
between hair characteristics (e.g. hair treatment in the past 3
months, heavy transpiration, hair product use before hair collec-
tion) in mothers (P > 0.201) or infants (P > 0.577), or between
timing of the hair sample (range 34–84 days’ postpartum) and
infant HCC (P = 0.770); accordingly, we did not control for these
variables in the regression analyses. To adjust for the effects of
other potential confounders, we calculated a propensity score
including all available confounders as summarised in subheading
’Covariates and potential confounders’, and included the propensity
score as a single covariate in all analyses.58 Differences in maternal–
infant HCC associations between the patient and control samples
were tested with Fisher z-scores.
We also explored whether maternal symptom severity was
related to HCC in mothers and infants. Therefore, we estimated
the association between perinatal symptom severity levels (based
on BSI scores) and maternal and infant HCCs, using regression ana-
lysis. We conducted a sensitivity analysis, repeating the regression
analysis but leaving out two outliers.
Results from the regression analyses are reported as correlation
coefficient (r) and s.e.59 Q-Q plots were used to check all data for
normality of the distribution. HCC data were checked for extreme
outliers (defined as below quartile 1 (Q1)− 1.5 interquartile
range (IQR) or above quartile 3 (Q3) + 1.5 interquartile
range (IQR)), which were removed from all analyses (n = 4).
Statistical analyses were performed with SPSS version 24 for
Windows (IBM, New York, USA).
Results
Background and clinical characteristics
A sample description is displayed in Tables 1 and 2. Mothers in the
patient and control group did not differ with regard to age and eth-
nicity. Lower educational level and smoking were more common
among patients. Expectedly, infants of patients had a significantly
lower gestational age and birth weight compared with control
infants.46,60 In the patient group, depressive and anxiety disorders
were most common (33.3 and 51.1%, respectively), followed by
bipolar disorders (18.2%). A considerable percentage of mothers
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(39.4%) had two or more Axis I disorders (e.g. depressive disorder
and panic disorder). Furthermore, half of the patients had a comorbid
personality disorder (48.4%), mostly in Cluster C (avoidant, depend-
ent or obsessive–compulsive personality disorder). Approximately
two-thirds (67.7%) of the patient group used psychotropic medica-
tion during pregnancy, which were mostly antidepressants, followed
by antipsychotics and hypnotics. A smaller group of mothers used
two or more psychotropic medications (19.4%).
Differences in HCCs between patient and control dyads
HCC of patient and control dyads are displayed in Fig. 1. Median
(interquartile range) and distribution of HCCwere significantly differ-
ent in patients compared with control mothers (U = 468.5, P = 0.03).
Results did not differ in infants of patients (U = 250.0, P = 0.67).
Correlation of HCCs within clinical and control
mother–infant dyads
We found a positive correlation between maternal perinatal
HCC and infant HCC in the control group (n = 27, r = 0.55 (0.14),
P = 0.003). The correlation between maternal perinatal HCC
and infant HCC in the patient group was non-significant (n = 18,
r = 0.082 (0.13), P = 0.746; see Fig. 2). The correlations between
maternal perinatal HCC and infant HCCwere significantly different
across the patient and control group (z =−1.64, P = 0.05). The
correlation analyses were repeated with the propensity score, to
adjust for confounders. After adjustment, the strength of the
correlation between HCCs in control mother–infant dyads
increased somewhat (r = 0.65 (0.13), P = 0.001). In patient
mother–infant dyads, the correlation increased greatly, but
remained non-significant (r = 0.37 (0.13), P = 0.16).
Correlation of current maternal symptom severity with
HCCs in patient dyads
We explored if maternal symptom severity in the perinatal period is
correlated with maternal and infant HCC. Results are displayed in
Fig. 3.
In mothers, symptom severity was not correlated with HCC (n
= 23, r =−0.09 (0.12), P = 0.67). In infants, a positive correlation
between maternal perinatal symptom severity and HCC was
found (n = 16, r = 0.63 (0.06), P = 0.008). The correlation analyses
were repeated with the propensity score, to adjust for confounders.
After adjustment, the strength of the correlation between symptom
severity and maternal perinatal HCC (r = 0.08 (0.13), P = 0.70) and
infant HCC (r = 0.59 (0.18), P = 0.02) remained in a similar range.
In the sensitivity analysis, leaving out the two outlier infants on
the right, the strength of the correlation between maternal
symptom severity and infant HCC remained in a similar range as
our original result.
Discussion
In this study, we explored the influence of severe psychiatric disor-
ders on HCCs of mothers and newborn infants. We found a signifi-
cantly wider range of HCCs in mothers with severe psychiatric
disorders compared with controls, but we did not find differences
in infants. We also found that HCC of patients and infants of
patients were not associated, whereas in control dyads, we found
a significant positive association between mother and child HCCs.
In infants of patients, HCCs were positively associated with mater-
nal symptom severity.
HCCs in patient and control groups
In our study, a significant variation in HCC was found in mothers
with psychopathology, showing both (mainly) higher and lower
values than control mothers. One explanation for this finding is
the nature of our clinical sample, in which women with severe
and long-lasting psychiatric disorders were selected. Previous
studies have shown cortisol levels in patients with mood disorders
change over time. First episodes are more often associated with
higher cortisol levels, whereas long-term duration and recurrence
of episodes might diminish the sensitivity of the HPA axis over
time.6,61 Heterogeneity of psychiatric diagnoses and high prevalence
of medication use might also be critical factors in differences of HPA
axis functioning and long-term release of cortisol in affected
mothers.19,62
Infants of patients showed no significant differences with regard
to variation inHCC compared with control infants. Previous studies
have shown that higher maternal perinatal HCC predicted lower
HCC in newborn infants early postpartum.33,39 We could not rep-
licate this finding. Three factors may contribute to this inconsis-
tence. First, the sample size of our study might not have been
sufficient to uncover differences in our patient dyads. Second, the
mothers in the aforementioned studies were healthy or subject to
mood and anxiety disorders and only used antidepressants,
whereas patients in this study had high rates of comorbidity and
Table 2 Clinical characteristics of patients (n = 33)
Maternal psychiatric characteristics N (%)
Axis I psychiatric disorder
Depressive disorder, n (%) 11 (33.3)
Anxiety disorder, n (%) 17 (51.1)
Psychotic disorder, n (%) 2 (6.1)
Bipolar disorder, n (%) 6 (18.2)
Comorbidity (≥2 Axis I disorders), n (%) 13 (39.4)
Axis II personality disorder
Cluster A, n (%) 5 (16.1)
Cluster B, n (%) 3 (9.7)
Cluster C, n (%) 10 (32.3)
No personality disorder, n (%) 16 (51.6)
Psychotropic medication usea
SSRI/SNRI/TCA, n (%) 14 (45.2)
Antipsychotics, n (%) 8 (25.8)
Hypnotics/anxiolytics, n (%) 3 (9.1)
≥2 psychotropic medications, n (%) 6 (19.4)
No psychotropic medication use, n (%) 10 (32.3)
SSRI, Selective Serotonin Reuptake Inhibitor; SNRI, Selective Serotonin and Noradrenalin
Reuptake Inhibitor; TCA, Tricyclic Antidepressants.
a. Any exposure during pregnancy.
Table 1 Demographic characteristics of patients (n = 33), control






Maternal age, years, mean (s.d.) 32.2 (6.0) 31.9 (4.4) 0.12
Maternal ethnicity, White, n (%) 27 (81.8) 32 (88.9) 0.41
Education level, low, n (%) 27 (84.4) 16 (45.7) 0.001
Tobacco use 11 (33.3) 3 (8.3) 0.008
Gestational age, weeks, mean (s.d.) 38.3 (1.9) 39.7 (1.3) 0.002
Infant birth weight, grams,
mean (s.d.)
3227 (456) 3652 (608) 0.002
Infant gender, male, n (%) 13 (66.7) 18 (45.0) 0.06
Maternal symptom severity
Brief Symptom Inventory, mean GSI
score (s.d.)
0.95 (0.66)a 0.21 (0.23)a <0.001
GSI, Global Severity Index.
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other medication use (including antipsychotics). Third, the absence
of marked differences of HCC in infants of the patient group might
reflect that foetal exposure to increased or decreased maternal cor-
tisol concentrations during pregnancy is effectively regulated by the
dynamic nature of placental 11β-hydroxysteroid dehydrogenase
type II (11β-HSD-2).63
Prenatal synchrony of HCCs between mother and child
In line with previous studies,17,39 we found a positive association
between maternal and infant HCC in healthy control dyads. This
finding might reflect early physiological synchrony, which is
defined as the matching of biological states between mother and
child that develops via interactions among genetic predispositions,
prenatal programming and postnatal behaviour.64,65 In mother–
infant dyads subject to severe psychiatric disorders, we found a
divergence of this pattern. This might indicate that synchrony of
the HPA axis betweenmother and childmight be prenatally affected
by the presence of a maternal psychiatric disorder. This finding
should be interpreted with caution because the two groups in this
study differed with regards to relevant demographic and obstetric





















































Fig. 1 Distribution of hair cortisol concentrations (HCCs) in patient versus control mothers, and infants of patients versus infants of controls.
Median (interquartile range) and distribution of HCCswere significantly different in patients compared with control mothers (U = 468.5, P = 0.03).



























Fig. 2 Correlation between mother and infant log-transformed hair cortisol concentrations (HCCs). Figure based on unadjusted results.
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and gestational age in infants of patients), but it should also be noted
that the findings remained the same when these factors were con-
trolled for.
HCCs and (self-reported) symptom severity
We did not find a correlation between maternal perinatal HCC and
self-reported symptom severity at 6 weeks’ postpartum. Because of
the previously mentioned blunted cortisol responses in long-lasting
psychopathology, the absence of an association between HCC and
maternal-reported stress levels might indicate reduced responsive-
ness of the HPA axis to stressful experiences.7 However, the rela-
tionship between the human concept of stress and HPA axis
functioning is an ongoing subject of debate. A recent meta-analysis
of Kalliokoski et al66 on hair glucocorticoids as a measure of stress
suggests that self-reported assessments of stress poorly correlate
with HPA axis functioning. Furthermore, symptom assessments
in our study were obtained postpartum, which is an especially
chaotic transition in a woman’s life. It might not be accurate to
relate this to cortisol levels that presumably reflect third trimester
exposure of cortisol. It also cannot be ruled out that other physical
factors that are important determinants of cortisol levels, such as
obesity, metabolic syndrome and cardiovascular disease, were over-
represented in the patient group compared with the control group,
and therefore may have influenced the outcomes.67,68
Interestingly, in infants of patients, we found that highermaternal
symptom severity was associated with higher infant HCC, after stat-
istically controlling for known covariates of HCC. There are several
possible explanations for this finding. It has been proposed that the
placental barrier function, inactivating cortisol by 11β- HSD-2, may
be impaired by stress,44,69 allowing an increased passage of maternal
cortisol to the foetus.63 Also the production of placental cortico-
tropin-releasing hormone (CRH) might be reacting to blunting of
the maternal HPA axis, leading to stimulation of the foetal
adrenal.70 Stressful circumstances during delivery and in the post-
partum period might also contribute to higher infant HCC.
However, this finding is subject to the same limitations (i.e. maternal
self-reported stress) as in mothers, and has to be interpreted with
caution.
Strengths and limitations
Our study has several strengths and limitations. The foremost
strength of this study is our patient sample of mothers with
various severe psychiatric disorders, representing the heterogeneity
of clinical populations. Further strengths are the non-invasive
measurement of chronic stress in hair performed with the state-
of-the-art liquid chromatography with tandem mass spectrometry
method, and the availability of detailed and reliable diagnostic infor-
mation, as well as the possibility to adjust for various covariates.
Limitations include the limited sample size of subgroups, which
only allowed for an initial exploration. Additionally, we only mea-
sured psychiatric symptom severity at 6 weeks’ postpartum, and
could therefore not take into account the possible variation of symp-
toms over time.
Conclusions and future research
In the current study, we observed differences in the association
between HCCs of patients and their infants compared with
healthy controls and their infants. Where in healthy control dyads
there seems to be perinatal synchrony of HPA axis functioning in
mother and infant, our findings suggest there is a divergence of
this pattern in mother–infant dyads subjected to long-lasting and
severe psychiatric disorders. In infants, these early differences
might influence lifetime HPA axis functioning, as has been sug-
gested in previous research.28 In turn, altered HPA axis functioning
may increase susceptibility to disease, both physically and mentally.
Future longitudinal studies in larger clinical samples should
examine howmaternal and infant hair cortisol levels are intertwined
perinatally, in the early postpartum period and beyond.
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Fig. 3 Association betweenmaternal symptom severity bymeans of the Global Severity Index and log-transformed hair cortisol concentrations
(HCCs) of patients (left) and infants of patients (right). Figure based on unadjusted results.
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Appendix: flowchart
Inclusion in INCAS study
30th week of pregnancy
Patients: n = 54 Controls:  n = 75
Patients: n = 36
Infants of patients: n = 24
Participants consenting to hair 
donation at 6 weeks postpartum
Controls: n = 47
Infants of controls: n = 34
Patients: n = 33
Infants of patients: n = 20
Controls: n = 40
Infants of controls: n = 27
Exclusion of participants:
patients: n = 3, infants: n = 4
Exclusion of participants:
controls: n = 7, infants: n = 7
Reasons for exclusion:
- withdrawal of consent
- insufficient amount of hair or 
unreliable cortisol measurement
- perinatal complications 
(prematurity, infection)
- corticosteroid use
- Global Severity Index score in clinical
range or use of psychotropic
medication (controls) 
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